Stocks and Investing
Stocks and Investing
Fri, May 1, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (TNDM) at Hold with Increased Target to $81 on, May 1st, 2020
Joanne Wuensch of Citigroup, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Increased Target from $74 to $81 on, May 1st, 2020.
Joanne has made no other calls on TNDM in the last 4 months.
There are 3 other peers that have a rating on TNDM. Out of the 3 peers that are also analyzing TNDM, 1 agrees with Joanne's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeff Johnson of "Baird" Downgraded from Buy to Hold and Increased Target to $75 on, Tuesday, February 4th, 2020
These are the ratings of the 2 analyists that currently disagree with Joanne
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $81 on, Monday, April 27th, 2020
- Matt OBrien of "Piper Sandler" Maintained at Buy with Increased Target to $90 on, Tuesday, February 25th, 2020